Broadfin Capital, LLC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 55 filers reported holding ADMA BIOLOGICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2019$2,251,000
-22.2%
505,900
-32.3%
0.42%
-33.9%
Q2 2019$2,893,000
-48.4%
747,500
-49.5%
0.63%
-45.7%
Q1 2019$5,606,000
-44.5%
1,479,243
-65.0%
1.16%
-12.8%
Q4 2018$10,100,000
-63.6%
4,226,077
-5.3%
1.33%
-67.4%
Q3 2018$27,720,000
+89.1%
4,463,829
+37.4%
4.08%
+76.8%
Q2 2018$14,657,000
+342.3%
3,249,829
+351.0%
2.31%
+347.1%
Q1 2018$3,314,000
-6.3%
720,529
-34.6%
0.52%
-10.7%
Q4 2017$3,538,000
+40.3%
1,102,200
+61.8%
0.58%
+88.9%
Q2 2017$2,521,000
-49.8%
681,346
-33.8%
0.31%
-49.7%
Q1 2017$5,020,000
-11.9%
1,028,672
-7.6%
0.61%
-3.9%
Q4 2016$5,700,000
-29.3%
1,113,2930.0%0.63%
-12.3%
Q3 2016$8,060,000
+21.7%
1,113,2930.0%0.72%
+12.1%
Q2 2016$6,624,000
-15.1%
1,113,293
+15.5%
0.64%
-14.5%
Q1 2016$7,800,000
+0.2%
964,1930.0%0.75%
+57.2%
Q4 2015$7,781,000
-3.5%
964,1930.0%0.48%
+6.9%
Q3 2015$8,061,000
-9.7%
964,1930.0%0.45%
-6.7%
Q2 2015$8,928,000
-5.5%
964,1930.0%0.48%
-34.8%
Q1 2015$9,449,000
+8.7%
964,193
+23.9%
0.74%
+94.7%
Q4 2014$8,694,000778,3860.38%
Other shareholders
ADMA BIOLOGICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Biomark Capital Management Co. LLC 1,433,304$6,464,00099.88%
Broadfin Capital, LLC 3,249,829$14,657,0002.31%
Stonepine Capital Management, LLC 831,731$3,751,0002.28%
Aisling Capital LLC 3,608,171$16,273,0002.14%
Consonance Capital Management LP 4,249,234$19,164,0001.24%
MORGENS WATERFALL VINTIADIS & CO INC 375,000$1,691,0001.20%
Perceptive Advisors 6,521,102$29,410,0000.77%
PURA VIDA INVESTMENTS, LLC 325,000$1,466,0000.59%
683 Capital Management, LLC 885,000$3,991,0000.27%
ARDSLEY ADVISORY PARTNERS LP 80,000$361,0000.05%
View complete list of ADMA BIOLOGICS INC shareholders